Advanced search
Add to list

Pharmacoepidemiology in pediatrics : needs, challenges and future directions for research

(2018) THÉRAPIE. 73(2). p.151-156
Author
Organization
Abstract
Despite international initiatives to promote clinical research in pediatrics, there are still many gaps of knowledge in the use of drugs to treat this specific population. When important information cannot be derived only from clinical trials, use of available observational research tools is required. In this paper, we provide an overview of the particular interest of pharmacoepidemiological research into the evaluation of drug effects in children and adolescents. We also sought to underline the unique challenges and specific needs regarding this research. Implementation of innovative methodologies and expansion of database networks to perform necessary studies could further improve performances of observational research. (C) 2018 Societe francaise de pharmacologie et de therapeutique.
Keywords
Pediatrics, Pharmacoepidemiology, Drug development, Challenges, DRUG-DEVELOPMENT, EXTRAPOLATION, DATABASES, OUTCOMES, ASTHMA, IMPACT

Citation

Please use this url to cite or link to this publication:

MLA
Osokogu, Osemeke U., et al. “Pharmacoepidemiology in Pediatrics : Needs, Challenges and Future Directions for Research.” THÉRAPIE, vol. 73, no. 2, 2018, pp. 151–56, doi:10.1016/j.therap.2017.11.009.
APA
Osokogu, O. U., Verhamme, K., Sturkenboom, M., & Kaguelidou, F. (2018). Pharmacoepidemiology in pediatrics : needs, challenges and future directions for research. THÉRAPIE, 73(2), 151–156. https://doi.org/10.1016/j.therap.2017.11.009
Chicago author-date
Osokogu, Osemeke U, Katia Verhamme, Miriam Sturkenboom, and Florentia Kaguelidou. 2018. “Pharmacoepidemiology in Pediatrics : Needs, Challenges and Future Directions for Research.” THÉRAPIE 73 (2): 151–56. https://doi.org/10.1016/j.therap.2017.11.009.
Chicago author-date (all authors)
Osokogu, Osemeke U, Katia Verhamme, Miriam Sturkenboom, and Florentia Kaguelidou. 2018. “Pharmacoepidemiology in Pediatrics : Needs, Challenges and Future Directions for Research.” THÉRAPIE 73 (2): 151–156. doi:10.1016/j.therap.2017.11.009.
Vancouver
1.
Osokogu OU, Verhamme K, Sturkenboom M, Kaguelidou F. Pharmacoepidemiology in pediatrics : needs, challenges and future directions for research. THÉRAPIE. 2018;73(2):151–6.
IEEE
[1]
O. U. Osokogu, K. Verhamme, M. Sturkenboom, and F. Kaguelidou, “Pharmacoepidemiology in pediatrics : needs, challenges and future directions for research,” THÉRAPIE, vol. 73, no. 2, pp. 151–156, 2018.
@article{8591128,
  abstract     = {{Despite international initiatives to promote clinical research in pediatrics, there are still many gaps of knowledge in the use of drugs to treat this specific population. When important information cannot be derived only from clinical trials, use of available observational research tools is required. In this paper, we provide an overview of the particular interest of pharmacoepidemiological research into the evaluation of drug effects in children and adolescents. We also sought to underline the unique challenges and specific needs regarding this research. Implementation of innovative methodologies and expansion of database networks to perform necessary studies could further improve performances of observational research. (C) 2018 Societe francaise de pharmacologie et de therapeutique.}},
  author       = {{Osokogu, Osemeke U and Verhamme, Katia and Sturkenboom, Miriam and Kaguelidou, Florentia}},
  issn         = {{0040-5957}},
  journal      = {{THÉRAPIE}},
  keywords     = {{Pediatrics,Pharmacoepidemiology,Drug development,Challenges,DRUG-DEVELOPMENT,EXTRAPOLATION,DATABASES,OUTCOMES,ASTHMA,IMPACT}},
  language     = {{eng}},
  number       = {{2}},
  pages        = {{151--156}},
  title        = {{Pharmacoepidemiology in pediatrics : needs, challenges and future directions for research}},
  url          = {{http://doi.org/10.1016/j.therap.2017.11.009}},
  volume       = {{73}},
  year         = {{2018}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: